Reviewed By
Overview
SCIENTIFIC SCORE
Possibly Effective
Based on 16 Researches
7.3
USERS' SCORE
Good
Based on 2 Reviews
8
Supplement Facts
Serving Size: 1 Tbsp (About 15 ml)
Serving Per Container: 63
Amount Per Serving
%DV
Calories
130
Total Fat
14 g
17%*
Saturated Fat
14 g
70%*
Trans Fat
0 g
+
Polyunsaturated Fat
0 g
+
Monounsaturated Fat
0 g
+
Cholesterol
0 mg
0%
Medium Chain Triglycerides (MCTs)
13 g **
+
C8:0 - Caprylic Acid
8 g **
C10:0 - Capric Acid
5 g **
Top Medical Research Studies
9
MCT oil shows promise for NAFLD
We investigated the effects of medium-chain triglycerides (MCTs) on non-alcoholic fatty liver disease (NAFLD) induced by obesity. By treating mice with various dietary fats over 16 weeks, we observed that MCTs significantly improved weight and blood lipid levels, and reduced liver fat more effectively than traditional vegetable oils. Significant changes in bile acid composition were also noted, with MCTs promoting beneficial FXR signaling. Overall, MCTs demonstrated a promising potential in managing NAFLD, offering a better option than common long-chain oils.
Read More
2
We explored how medium-chain triglyceride (MCT) oil affects liver health, particularly regarding damage caused by high fructose intake in mice. Over 12 weeks, we divided young mice into four groups to assess various health markers.
Surprisingly, we found that both groups receiving MCT oil exhibited liver issues, despite the expectation of improvement. The mice consuming fructose with MCT oil did not worsen the liver damage but still showed notable signs of hepatic steatosis and inflammation.
Overall, our findings suggest that MCT oil might lead to harmful liver effects, emphasizing the need for caution in its use, especially when liver health is already compromised.
Surprisingly, we found that both groups receiving MCT oil exhibited liver issues, despite the expectation of improvement. The mice consuming fructose with MCT oil did not worsen the liver damage but still showed notable signs of hepatic steatosis and inflammation.
Overall, our findings suggest that MCT oil might lead to harmful liver effects, emphasizing the need for caution in its use, especially when liver health is already compromised.
Read More
9
MCT oil improves GSD-1 outcomes
We examined how medium-chain triglyceride (MCT) oil, combined with a specialized diet, influences children suffering from glycogen storage disease type 1 (GSD-1) in Jordan.
Over three months, we assessed 38 children and observed a dramatic reduction in hypoglycaemia, from nearly 95% to about 8%. There were also significant drops in triglycerides, cholesterol, and uric acid levels.
Importantly, we noted improvements in liver size and various growth parameters, indicating that MCT oil can positively impact metabolic health in this population.
Over three months, we assessed 38 children and observed a dramatic reduction in hypoglycaemia, from nearly 95% to about 8%. There were also significant drops in triglycerides, cholesterol, and uric acid levels.
Importantly, we noted improvements in liver size and various growth parameters, indicating that MCT oil can positively impact metabolic health in this population.
Read More
Most Useful Reviews
7
Supports dieting
Due to the medium-chain triglycerides derived from coconut oil, this MCT oil converts fats and sugars into energy, while the muscles around my liver have become very soft. I've gradually felt satisfied and it has assisted my dieting efforts. I've used it for a year and a half with no habit-forming effects, so it comes highly recommended. This size is great as it serves two people.
Read More
4
Caution advised
1 people found this helpful
A good product, but it should be consumed in moderation as it is hard for the liver to process.
Read More
Medical Researches
SCIENTIFIC SCORE
Possibly Effective
Based on 16 Researches
7.3
- All Researches
9
MCT oil shows promise for NAFLD
We investigated the effects of medium-chain triglycerides (MCTs) on non-alcoholic fatty liver disease (NAFLD) induced by obesity. By treating mice with various dietary fats over 16 weeks, we observed that MCTs significantly improved weight and blood lipid levels, and reduced liver fat more effectively than traditional vegetable oils. Significant changes in bile acid composition were also noted, with MCTs promoting beneficial FXR signaling. Overall, MCTs demonstrated a promising potential in managing NAFLD, offering a better option than common long-chain oils.
Read More
9
MCT oil improves GSD-1 outcomes
We examined how medium-chain triglyceride (MCT) oil, combined with a specialized diet, influences children suffering from glycogen storage disease type 1 (GSD-1) in Jordan.
Over three months, we assessed 38 children and observed a dramatic reduction in hypoglycaemia, from nearly 95% to about 8%. There were also significant drops in triglycerides, cholesterol, and uric acid levels.
Importantly, we noted improvements in liver size and various growth parameters, indicating that MCT oil can positively impact metabolic health in this population.
Over three months, we assessed 38 children and observed a dramatic reduction in hypoglycaemia, from nearly 95% to about 8%. There were also significant drops in triglycerides, cholesterol, and uric acid levels.
Importantly, we noted improvements in liver size and various growth parameters, indicating that MCT oil can positively impact metabolic health in this population.
Read More
9
MCT reduces alcohol-related liver fat
We examined the effects of medium chain triglycerides (MCT) on liver health, particularly in the context of alcohol consumption. Over eight weeks, male rats were fed diets containing control, alcohol, and MCT with alcohol.
The results showed that MCT reduced liver fat accumulation linked to alcohol while preserving critical liver proteins. MCT helped balance the fatty acid levels and normalized several liver genes affected by alcohol.
Ultimately, we found that MCT could offer liver protection from the harmful effects of alcohol by maintaining important cellular functions.
The results showed that MCT reduced liver fat accumulation linked to alcohol while preserving critical liver proteins. MCT helped balance the fatty acid levels and normalized several liver genes affected by alcohol.
Ultimately, we found that MCT could offer liver protection from the harmful effects of alcohol by maintaining important cellular functions.
Read More
9
We examined the effects of a novel medium-chain triglyceride and fish oil emulsion on liver fat in omega-3-depleted rats. By injecting this emulsion, we found that liver cells significantly increased their omega-3 fatty acid content and experienced a noticeable reduction in fatty liver.
Our study suggests that bolus intravenous administration of this emulsion may quickly replenish omega-3s in liver cells, potentially correcting biochemical deficiencies. However, more research is needed to understand the full implications for liver disease treatment.
Our study suggests that bolus intravenous administration of this emulsion may quickly replenish omega-3s in liver cells, potentially correcting biochemical deficiencies. However, more research is needed to understand the full implications for liver disease treatment.
Read More
8
MCT may improve liver function
We explored the impact of medium-chain triglycerides (MCT) on liver health in piglets facing challenges due to intra-uterine growth retardation (IUGR). By comparing piglets on a conventional soy oil diet with those receiving a diet rich in MCT, we observed that the latter group showed improved daily growth and feed efficiency.
Additionally, the MCT diet enhanced the liver's ability to manage oxidative damage, indicated by higher glutathione levels and reduced cell death in the liver. Overall, our findings suggest that MCT might offer a supportive therapy for young animals with liver stress.
Additionally, the MCT diet enhanced the liver's ability to manage oxidative damage, indicated by higher glutathione levels and reduced cell death in the liver. Overall, our findings suggest that MCT might offer a supportive therapy for young animals with liver stress.
Read More
User Reviews
USERS' SCORE
Good
Based on 2 Reviews
8
- All Reviews
- Positive Reviews
- Negative Reviews
7
Supports dieting
Due to the medium-chain triglycerides derived from coconut oil, this MCT oil converts fats and sugars into energy, while the muscles around my liver have become very soft. I've gradually felt satisfied and it has assisted my dieting efforts. I've used it for a year and a half with no habit-forming effects, so it comes highly recommended. This size is great as it serves two people.
Read More
4
Caution advised
1 people found this helpful
A good product, but it should be consumed in moderation as it is hard for the liver to process.
Read More
Frequently Asked Questions
No FAQs are available for this product and symptom.
References
- Yue H, Jia M, Li B, Zong A, Du F, et al. Medium chain triglycerides alleviate non-alcoholic fatty liver disease through bile acid-mediated FXR signaling pathway: A comparative study with common vegetable edible oils. J Food Sci. 2024;89:10171. 10.1111/1750-3841.17565
- Subih HS, Qudah RA, Janakat S, Rimawi H, Elsahoryi NA, et al. Medium-Chain Triglyceride Oil and Dietary Intervention Improved Body Composition and Metabolic Parameters in Children with Glycogen Storage Disease Type 1 in Jordan: A Clinical Trial. Foods. 2024;13. 10.3390/foods13071091
- Wassef J, Lipkin E, Hardigan P, Duro D. Trends in liver profile and nutrition outcomes in children undergoing intestinal rehabilitation using a mixed lipid injectable emulsion. Nutr Clin Pract. 2022;37:1180. 10.1002/ncp.10782
- Klek S, Szczepanek K, Scislo L, Walewska E, Pietka M, et al. Intravenous lipid emulsions and liver function in adult chronic intestinal failure patients: Results after 5 y of home parenteral nutrition. Nutrition. 2021;82:111029. 10.1016/j.nut.2020.111029
- Baker MA, Cho BS, Anez-Bustillos L, Dao DT, Pan A, et al. Fish oil-based injectable lipid emulsions containing medium-chain triglycerides or added α-tocopherol offer anti-inflammatory benefits in a murine model of parenteral nutrition-induced liver injury. Am J Clin Nutr. 2019;109:1038. 10.1093/ajcn/nqy370
- Guimarães J, Bargut TCL, Mandarim-de-Lacerda CA, Aguila MB. Medium-chain triglyceride reinforce the hepatic damage caused by fructose intake in mice. Prostaglandins Leukot Essent Fatty Acids. 2019;140:64. 10.1016/j.plefa.2018.11.005
- Pereira-da-Silva L, Nóbrega S, Rosa ML, Alves M, Pita A, et al. Parenteral nutrition-associated cholestasis and triglyceridemia in surgical term and near-term neonates: A pilot randomized controlled trial of two mixed intravenous lipid emulsions. Clin Nutr ESPEN. 2017;22:7. 10.1016/j.clnesp.2017.08.007
- Chamma CM, Bargut TC, Mandarim-de-Lacerda CA, Aguila MB. A rich medium-chain triacylglycerol diet benefits adiposity but has adverse effects on the markers of hepatic lipogenesis and beta-oxidation. Food Funct. 2017;8:778. 10.1039/c6fo01663d
- Carlson SJ, Nandivada P, Chang MI, Mitchell PD, O'Loughlin A, et al. The addition of medium-chain triglycerides to a purified fish oil-based diet alters inflammatory profiles in mice. Metabolism. 2015;64:274. 10.1016/j.metabol.2014.10.005
- Zhang H, Chen Y, Li Y, Yang L, Wang J, et al. Medium-chain TAG attenuate hepatic oxidative damage in intra-uterine growth-retarded weanling piglets by improving the metabolic efficiency of the glutathione redox cycle. Br J Nutr. 2014;112:876. 10.1017/S000711451400155X
- Pichler J, Simchowitz V, Macdonald S, Hill S. Comparison of liver function with two new/mixed intravenous lipid emulsions in children with intestinal failure. Eur J Clin Nutr. 2014;68:1161. 10.1038/ejcn.2014.118
- Zhong W, Li Q, Xie G, Sun X, Tan X, et al. Dietary fat sources differentially modulate intestinal barrier and hepatic inflammation in alcohol-induced liver injury in rats. Am J Physiol Gastrointest Liver Physiol. 2013;305:G919. 10.1152/ajpgi.00226.2013
- Ronis MJ, Baumgardner JN, Sharma N, Vantrease J, Ferguson M, et al. Medium chain triglycerides dose-dependently prevent liver pathology in a rat model of non-alcoholic fatty liver disease. Exp Biol Med (Maywood). 2013;238:151. 10.1258/ebm.2012.012303
- Li Q, Zhong W, Qiu Y, Kang X, Sun X, et al. Preservation of hepatocyte nuclear factor-4α contributes to the beneficial effect of dietary medium chain triglyceride on alcohol-induced hepatic lipid dyshomeostasis in rats. Alcohol Clin Exp Res. 2013;37:587. 10.1111/acer.12013
- Carpentier YA, Peltier S, Portois L, Sebedio JL, Leverve X, et al. Rapid reduction of liver steatosis in omega3-depleted rats injected with a novel lipid emulsion. Horm Metab Res. 2008;40:875. 10.1055/s-0028-1083781
- Lieber CS, DeCarli LM, Leo MA, Mak KM, Ponomarenko A, et al. Beneficial effects versus toxicity of medium-chain triacylglycerols in rats with NASH. J Hepatol. 2008;48:318.
